Omkar Speciality Chemicals is currently trading at Rs. 127.75, up by 5.20 points or 4.24% from its previous closing of Rs. 122.55 on the NSE.
The scrip opened at Rs. 132.00and has touched a high and low of Rs. 132.00 and Rs. 124.10 respectively. So far 1, 52,326 shares were traded on the counter.
The NSE stock of face value Rs. 10 has touched a 52 week high of Rs. 132.20 on 21-Nov-2012 and a 52 week low of Rs. 52.90 on 06-Jan-2012. The current market cap of the company is Rs. 60.29 crore.
The promoters holding in the company stood at 60.24% while Institutions and Non-Institutions held 8.44% and 31.32% respectively.
Omkar Speciality Chemicals’ (OSCL) has commissioned the plant of its wholly owned subsidiary - Urdhwa Chemicals Company located at Plot No C-4, Chiplun, Ratnagiri district in Maharashtra state. The plant with a capacity of 2,800 MTs per annum will manufacture a number of high value intermediates for pharma industry catering to essential life-saying drugs with the state of the art facility for production and quality control.
This plant will also open-up vast opportunity for OSCL to cater to the overseas market for supply of premium products. This facility has also thrown open possibilities for forward and backward integrations for some of the products being currently manufactured by OSCL in its existing facilities. The capacities of Urdhwa’s plant are already over booked with the reputed customers both domestic and international with whom OSCL is having long standing relations.
Besides, with the commissioning of the above facility, the status of various operational capacities in OSCL and its subsidiaries has reached a total capacity of 4600 MTs per annum. Further, with the R&D and IPR back-up of the company and the capacity revamp, OSCL is now geared up to take up new challenges in near future.
Omkar Speciality Chemicals is mainly engaged in the manufacture and sale of speciality chemicals viz., selenium compounds, iodine compounds, molybdenum compounds etc. and pharma intermediates viz., Potassium Iodate, Bismuth Ammonium Citrate, Bromoform etc.